Bookrunner Jefferies and co-manager Leerink Swann assist with sale
By Devika Patel
Knoxville, Tenn., Feb. 25 - Anthera Pharmaceuticals, Inc. reported that the underwriters for its public sale of stock opted to exercise the deal's $6 million greenshoe in full for total proceeds of $46 million. The offering was announced Jan. 24 and priced for $40 million on Jan. 25.
In an 8-K filing with the Securities and Exchange Commission, the company said it sold 69,696,970 common shares at $0.66 apiece. The price per share is an 8.33% discount to the Jan. 24 closing share price of $0.72. Of the shares, 9,090,909 were part of the fully exercised greenshoe.
Jefferies was the sole bookrunning manager, and Leerink Swann was the co-manager.
Settlement is expected Feb. 27.
Proceeds will be used for general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $46 million (including $6 million greenshoe)
|
| Shares: | 69,696,970
|
| Price: | $0.66
|
| Warrants: | No
|
| Bookrunner: | Jefferies
|
| Co-manager: | Leerink Swann
|
| Announcement date: | Jan. 24
|
| Pricing date: | Jan. 25
|
| Settlement date: | Feb. 27
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $0.72 at close Jan. 24
|
| Market capitalization: | $49.05 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
